IGL SMP moves to subsidiary EBL as Executive Director and KMP

Management Changes View source PDF Explain this filing

INDIAGLYCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹1144.50

prior close

₹1158.00

announcement price

After-mkt

timing

Nifty Microcap 250market+1.3%-1.7% vs market

Breweries & Distilleries peers, median of 25sector+1.0%-1.4% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.4 pts less than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.6

15m

-0.5

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+1.3-1.7+1.0-1.4

Next day

+1.8+1.8+0.0+1.1+0.7

+0.6+3.1-2.5+1.1-0.5

+0.4+3.5-3.0+1.0-0.6

-0.2+3.5-3.7+0.8-1.0

-5.4+3.4-8.8+0.5-5.9

-8.7+3.6-12.3+0.0-8.7

15d

+4.3+4.9-0.5-1.5+5.8

-78.3+4.4-82.7-1.8-76.5

-73.5+2.9-76.4-9.6-63.9

—————

UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India Glycols has transferred Akshay Bansal, Head Sales and Marketing of its Ennature Biopharma Division and a Senior Managerial Personnel, to wholly owned subsidiary Ennature Bio Pharma Limited effective July 30, 2026. EBL has appointed him as Additional Director (Executive Director) and KMP for a five year term till July 30, 2031. The move is part of the ongoing Scheme of Arrangement between IGL, EBL, and IGL Spirits Limited.

Likely market impact

Internal reshuffle tied to the scheme of arrangement. No change at IGL parent board level.